AbbVie hits go on $1B re-upped Calico deal as the Google life science spin-out continues I-O, neuro push
AbbVie hits go on $1B re-upped Calico deal as the [...]
AbbVie hits go on $1B re-upped Calico deal as the [...]
Merck women’s health spinout Organon bags preterm labor drug ahead [...]
Prothena rolls out preclinical data for anti-amyloid Alzheimer’s candidate to [...]
AbbVie posts new data on drug that could replace glasses [...]
Bayer poaches Ruettinger from Roche to head up early cancer [...]
Novel degrader of cancer-driving protein AKT slows prostate, breast tumors [...]
UPDATE: Half of Adverum pipeline ‘snaps out of existence’ as [...]
Lumos delays key hormone deficiency readout as COVID bites ntaylor [...]
Eli Lilly pens pact with Banner Alzheimer’s Institute for ‘virtual [...]
Seres Therapeutics’ microbiome therapy flops against placebo as shares go [...]